Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Submitted by
admin
on August 23, 2016 - 5:47pm
Source:
Bloomberg
News Tags:
Clovis Oncology
FDA
priority review
rucaparib
ovarian cancer
Headline:
Clovis Jumps as Cancer Drug Gets Priority for FDA Review
Do Not Allow Advertisers to Use My Personal information
